Clinical trial
Treatment of a Single Patient With CRD-TMH-001
NCT05514249 is registered in ClinicalTrials.gov with Cure Rare Disease, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of a Single Patient With CRD-TMH-001
- Lead sponsor
- Cure Rare Disease, Inc
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 31, 2022
- Completion date
- September 30, 2023
- Enrollment
- 1 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne muscular dystrophy